Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	782	521	523	542	601	730
Market Cap Growth	64.07%	-0.23%	-3.62%	-9.76%	-17.67%	100.53%
Enterprise Value	772	520	523	552	595	710
Last Close Price	81.70	54.30	53.41	54.47	59.24	70.91
PE Ratio	39.16	26.07	31.47	42.26	39.94	53.01
Forward PE	32.15	23.47	25.25	32.36	38.79	53.54
PS Ratio	5.92	3.95	4.50	5.39	7.24	10.71
PB Ratio	10.98	7.32	8.41	9.97	11.80	16.19
P/TBV Ratio	15.69	10.46	12.79	16.38	19.87	18.30
P/FCF Ratio	47.62	31.74	32.32	-	-	47.32
P/OCF Ratio	39.99	26.66	25.59	44.85	34.41	35.76
PEG Ratio	-	1.77	1.77	1.77	1.77	1.77
EV/Sales Ratio	5.84	3.94	4.50	5.49	7.16	10.41
EV/EBITDA Ratio	23.91	16.36	16.93	21.72	24.56	36.76
EV/EBIT Ratio	26.53	17.88	19.11	24.00	25.78	38.78
EV/FCF Ratio	47.00	31.68	32.33	-	-	46.00
Debt / Equity Ratio	0.29	0.29	0.39	0.52	0.35	0.14
Debt / EBITDA Ratio	0.64	0.64	0.79	1.10	0.73	0.33
Debt / FCF Ratio	1.25	1.25	1.50	-	-	0.41
Net Debt / Equity Ratio	-0.14	-0.14	-0.08	0.05	-0.18	-0.61
Net Debt / EBITDA Ratio	-0.32	-0.32	-0.15	0.11	-0.38	-1.43
Net Debt / FCF Ratio	-0.61	-0.61	-0.29	-2.50	1.05	-1.79
Asset Turnover	1.09	1.09	1.01	0.95	0.97	1.11
Inventory Turnover	8.28	8.28	7.53	7.76	10.13	15.13
Quick Ratio	1.86	1.86	1.94	1.70	1.96	3.08
Current Ratio	2.35	2.35	2.38	2.12	2.28	3.32
Return on Equity (ROE)	29.87%	29.87%	28.40%	24.36%	31.34%	33.26%
Return on Assets (ROA)	14.99%	14.99%	14.88%	13.54%	16.82%	18.58%
Return on Invested Capital (ROIC)	30.42%	32.39%	29.06%	25.63%	50.00%	74.25%
Return on Capital Employed (ROCE)	30.90%	30.90%	30.40%	27.20%	31.00%	33.50%
Earnings Yield	2.56%	3.84%	3.18%	2.37%	2.50%	1.89%
FCF Yield	2.10%	3.15%	3.09%	-0.21%	-1.45%	2.11%
Dividend Yield	1.47%	2.21%	1.87%	1.56%	1.35%	1.00%
Payout Ratio	47.95%	47.95%	49.20%	60.11%	45.53%	47.10%
Buyback Yield / Dilution	0.16%	0.16%	0.67%	0.05%	0.09%	-
Total Shareholder Return	1.66%	2.37%	2.54%	1.61%	1.44%	1.00%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.